Equlin
Company Screener
Try Lion AI
LoginSign Up

25+

Global Markets

25,000+

Companies Covered

1-3-5 Year

Forecast Horizon

Real-Time

Market Data

Equlin

Financial Forecasting Platform

AI-powered financial analysis and scenario modeling for institutional investors, analysts, and corporate finance teams worldwide.

256-bit SSLGDPR CompliantEncrypted

Platform

  • Company Screener
  • Data API
  • Financial Forecast
  • Methodology

Account

  • Login
  • Sign Up
  • Get a demo

Legal

  • Privacy Policy
  • Terms Of Services

Newsletter

Subscribe to our newsletter for weekly updates and promotions.

Copyright © Equlion 2026

256-bit SSL
All companies

Tango Therapeutics, Inc. (TNGX) Financial Forecast

United States · Health Care · USD (Thousands) · Annual

Key financials

USD|Thousands
ROE
-37.23%
2025 (actual)
ROA
-28.41%
2025 (actual)
Gross Margin
100%
2025 (actual)
Net Margin
-162.85%
2025 (actual)
Total Assets
$398,690.00K
2025 (actual)
Net Income
-$101,594.00K
2025 (actual)
Valuation
$1,493,887.85K
2025 (actual)
Stock Price
$8.86
2025 (actual)

Historical & projected performance

USD|Thousands

Reported figures and Equlion model projections for the next 5 years.

ROE

+237.1 pt
Company

Sector average (own scale)

ROA

-295.2 pt
Company

Gross Margin

+0 pt
Company

Sector average

Total Assets

-0.6%
Company

Sector average (own scale)

Net Income

-395,166,667,296,337,340%
Company

Sector average (own scale)

Valuation

+3,100%
Company

Sector average

Stock Price

+3,100%
Company

Sector average (own scale)

Detailed data

USD|Thousands
Key metricsActualForecast
Metric202520262027202820292030
ROE-37.23%571.95%199.93%199.91%199.91%199.91%
Sector average22.99%73.17%65.88%68.36%41.61%44.34%
ROA-28.41%-323.57%----
Gross Margin100%100%100%100%100%100%
Sector average45.84%46.72%46.7%45.37%44.33%43.24%
Total Assets$398,690.00K$259,363.79K$283,060.14K$326,593.43K$371,775.93K$396,457.76K
Sector average$3,516,665.42K$3,537,396.33K$3,954,880.66K$4,602,556.36K$5,424,035.31K$6,260,073.84K
Net Income-$101,594.00K-$1,064,647.86K-$4,239,701,756.08K-$19,324,423,529,740.38K-$88,079,800,397,222,880.00K-$401,465,623,973,041,100,000.00K
Sector average$134,662.15K-$3,310,917.35K-$20,355,009,519.97K-$452,079,671,182,724.94K-$10,847,990,944,801,638,000.00K-$264,345,605,315,870,720,000,000.00K
Valuation$1,493,887.85K$2,987,775.70K$5,975,551.40K$11,951,102.80K$23,902,205.60K$47,804,411.20K
Sector average$108,901,205.39K$221,258,895.17K$10,256,554.58K$8,537,157.01K$13,070,508.86K$21,933,198.76K
Stock Price$8.86$17.72$35.44$70.88$141.76$283.52
Sector average$144,483.77$100,191.80$2,039.92$56.28$76.25$107.63

Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2025. Projections are model estimates, not investment advice.

Want the full financial forecast report for Tango Therapeutics, Inc.? It covers the balance sheet, income statement, cash flow and Equlion model projections.